ATIP
ATI Physical Therapy, Inc. [ATIP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ATIP Stock Summary
Top 10 Correlated ETFs
ATIP
Top 10 Correlated Stocks
ATIP
In the News
ATIP Financial details
Company Rating
Neutral
Market Cap
17.26M
Income
-68.74M
Revenue
699.02M
Book val./share
28.72
Cash/share
8.85
Dividend
-
Dividend %
-
Employees
6K
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-0.16
Forward P/E
-
PEG
0.02
P/S
0.04
P/B
-0.29
P/C
0.46
P/FCF
-0.62
Quick Ratio
0.88
Current Ratio
1.03
Debt / Equity
4.73
LT Debt / Equity
4.12
-
-
EPS (TTM)
-16.67
EPS next Y
-
EPS next Q
-
EPS this Y
-86.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-2.3%
Revenue Q/Q
2.73%
EPS Q/Q
-63.11%
-
-
-
-
SMA20
-33.33%
SMA50
-33.33%
SMA100
-42.86%
Inst Own
0.13%
Inst Trans
0%
ROA
-17%
ROE
-624%
ROC
-0.04%
Gross Margin
15%
Oper. Margin
-5%
Profit Margin
-24%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.0-14.8
52W High
-71.21%
52W Low
+0.75%
RSI
24
Rel Volume
0.52
Avg Volume
5.58K
Volume
2.88K
Perf Week
-2.42%
Perf Month
-39.49%
Perf Quarter
-44.95%
Perf Half Y
-46.27%
-
-
-
-
Beta
0.26
-
-
Volatility
0.08%, 0.87%
Prev Close
-1.71%
Price
4.03
Change
0.5%
ATIP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 306.14 | 230.83 | 189.34 | 156.45 | 169.13 | |
| Net income per share | 3.8 | -0.12 | -235.83 | -121.35 | -16.89 | |
| Operating cash flow per share | 18.69 | 54.02 | -12.7 | -16.12 | -2.99 | |
| Free cash flow per share | 2.62 | 45.39 | -25.35 | -23.05 | -7.18 | |
| Cash per share | 14.93 | 55.39 | 14.66 | 20.46 | 8.9 | |
| Book value per share | 346.28 | 344.55 | 152.11 | 10.82 | 28.89 | |
| Tangible book value per share | -417.38 | -418.33 | -153.49 | -119.27 | -99.44 | |
| Share holders equity per share | 346.28 | 344.55 | 152.11 | 10.82 | 28.89 | |
| Interest debt per share | 477.76 | 543.43 | 273.94 | 207.48 | 151.37 | |
| Market cap | 1.28B | 1.38B | 562.08M | 61.96M | 25.38M | |
| Enterprise value | 1.24B | 2.54B | 1.37B | 776.52M | 738.76M | |
| P/E ratio | 131.59 | -4.62K | -0.72 | -0.13 | -0.36 | |
| Price to sales ratio | 1.63 | 2.32 | 0.9 | 0.1 | 0.04 | |
| POCF ratio | 26.76 | 9.93 | -13.35 | -0.95 | -2.05 | |
| PFCF ratio | 190.99 | 11.82 | -6.69 | -0.66 | -0.85 | |
| P/B Ratio | 1.44 | 1.56 | 1.11 | 1.41 | 0.21 | |
| PTB ratio | 1.44 | 1.56 | 1.11 | 1.41 | 0.21 | |
| EV to sales | 1.58 | 4.29 | 2.17 | 1.22 | 1.06 | |
| Enterprise value over EBITDA | 12.79 | 14.57 | 26.5 | 24.24 | 11.65 | |
| EV to operating cash flow | 25.96 | 18.33 | -32.43 | -11.85 | -59.74 | |
| EV to free cash flow | 185.28 | 21.81 | -16.24 | -8.29 | -24.88 | |
| Earnings yield | 0.01 | 0 | -1.39 | -7.96 | -2.75 | |
| Free cash flow yield | 0.01 | 0.08 | -0.15 | -1.51 | -1.17 | |
| Debt to equity | 1.28 | 1.48 | 1.69 | 18.15 | 4.73 | |
| Debt to assets | 0.5 | 0.5 | 0.55 | 0.74 | 0.49 | |
| Net debt to EBITDA | -0.39 | 6.68 | 15.59 | 22.3 | 11.25 | |
| Current ratio | 1.95 | 1.67 | 1.05 | 1.67 | 1.08 | |
| Interest coverage | 0.64 | 1.02 | -0.57 | -1.25 | -0.36 | |
| Income quality | 4.92 | -465.11 | 0.05 | 0.13 | 0.18 | |
| Dividend Yield | 0 | 0 | 0 | 2.58 | 0 | |
| Payout ratio | 0 | 0 | 0 | -0.32 | 0 | |
| Sales general and administrative to revenue | 0.14 | 0.17 | 0.17 | 0.17 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.86 | 0.76 | 0.65 | 0.49 | 0.47 | |
| Capex to operating cash flow | -0.86 | -0.16 | 1 | 0.43 | 1.4 | |
| Capex to revenue | -0.05 | -0.04 | -0.07 | -0.04 | -0.02 | |
| Capex to depreciation | -1.05 | -0.26 | -0.5 | -0.32 | -0.2 | |
| Stock based compensation to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Graham number | 172.06 | 30.01 | 898.4 | 171.87 | 104.77 | |
| ROIC | -0.01 | -0.01 | -0.02 | -0.05 | -0.03 | |
| Return on tangible assets | 0.03 | 0 | -1.44 | -0.9 | -0.11 | |
| Graham Net | -492.91 | -583.53 | -282.28 | -215.79 | -219.17 | |
| Working capital | 74.31M | 95.46M | 6.25M | 77.61M | 12.19M | |
| Tangible asset value | -1.07B | -1.07B | -509M | -484.59M | -410.97M | |
| Net current asset value | -1.23B | -1.47B | -907.61M | -836.41M | -858.37M | |
| Invested capital | 1.28 | 1.48 | 1.69 | 18.15 | 4.73 | |
| Average receivables | 0 | 97.16M | 86.58M | 81.56M | 96.58M | |
| Average payables | 0 | 11.3M | 13.65M | 13.85M | 13.63M | |
| Average inventory | 0 | 1.93M | 6.58M | 14.79M | 10.14M | |
| Days sales outstanding | 48.14 | 55.9 | 47.93 | 46.32 | 58.74 | |
| Days payables outstanding | 6.52 | 9.38 | 10.68 | 8.18 | 8.91 | |
| Days of inventory on hand | 0 | 2.98 | 6.56 | 13.21 | 0 | |
| Receivables turnover | 7.58 | 6.53 | 7.61 | 7.88 | 6.21 | |
| Payables turnover | 56 | 38.9 | 34.16 | 44.63 | 40.97 | |
| Inventory turnover | 585.01M | 122.47 | 55.62 | 27.64 | 0 | |
| ROE | 0.01 | 0 | -1.55 | -11.22 | -0.58 | |
| Capex per share | -16.07 | -8.63 | -12.66 | -6.93 | -4.19 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 40.77 | 40.73 | 41.81 | 42.72 | 43.85 | |
| Net income per share | -25.81 | -6.15 | -5.51 | -3.66 | -1.35 | |
| Operating cash flow per share | -1.62 | -3.47 | 2.16 | -3 | 1.3 | |
| Free cash flow per share | -3.15 | -4.8 | 1.06 | -4.11 | 0.64 | |
| Cash per share | 20.95 | 15.39 | 9.14 | 4.75 | 8.85 | |
| Book value per share | 11.08 | 3.81 | 34.13 | -22.67 | 28.72 | |
| Tangible book value per share | -122.13 | -125.02 | -95.87 | -150.56 | -98.86 | |
| Share holders equity per share | 11.08 | 3.81 | 34.13 | -22.67 | 28.72 | |
| Interest debt per share | 204.43 | 199.19 | 191.63 | 187.23 | 139.41 | |
| Market cap | 60.51M | 52.09M | 37.72M | 36.8M | 25.52M | |
| Enterprise value | 775.07M | 791.46M | 773.26M | 779.34M | 738.9M | |
| P/E ratio | -0.15 | -0.52 | -0.42 | -0.61 | -1.13 | |
| Price to sales ratio | 0.37 | 0.31 | 0.22 | 0.21 | 0.14 | |
| POCF ratio | -9.41 | -3.66 | 4.24 | -2.95 | 4.72 | |
| PFCF ratio | -4.85 | -2.65 | 8.67 | -2.16 | 9.53 | |
| P/B Ratio | 1.38 | 3.33 | 0.27 | -0.39 | 0.21 | |
| PTB ratio | 1.38 | 3.33 | 0.27 | -0.39 | 0.21 | |
| EV to sales | 4.79 | 4.74 | 4.49 | 4.39 | 4.05 | |
| Enterprise value over EBITDA | 55.56 | 80.61 | 92.52 | 92.57 | 31.15 | |
| EV to operating cash flow | -120.58 | -55.64 | 86.83 | -62.57 | 136.61 | |
| EV to free cash flow | -62.09 | -40.26 | 177.8 | -45.69 | 275.81 | |
| Earnings yield | -1.69 | -0.48 | -0.6 | -0.41 | -0.22 | |
| Free cash flow yield | -0.21 | -0.38 | 0.12 | -0.46 | 0.1 | |
| Debt to equity | 18.15 | 51.32 | 5.5 | -8.09 | 4.73 | |
| Debt to assets | 0.74 | 0.77 | 0.77 | 0.78 | 0.49 | |
| Net debt to EBITDA | 51.22 | 75.31 | 88 | 88.2 | 30.08 | |
| Current ratio | 1.67 | 1.5 | 1.1 | 1.03 | 1.08 | |
| Interest coverage | -0.61 | -0.84 | -0.74 | 0.05 | 0.17 | |
| Income quality | 0.06 | 0.56 | -0.41 | 0.85 | -0.96 | |
| Dividend Yield | 0.08 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.05 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.14 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.49 | 0.51 | 0.53 | 0.55 | 0.47 | |
| Capex to operating cash flow | 0.94 | 0.38 | -0.51 | 0.37 | -0.5 | |
| Capex to revenue | -0.04 | -0.03 | -0.03 | -0.03 | -0.01 | |
| Capex to depreciation | -0.27 | -0.25 | -0.21 | -0.49 | -0.13 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Graham number | 80.21 | 22.98 | 65.04 | 43.2 | 29.57 | |
| ROIC | -0.01 | -0.01 | -0.01 | 0 | 0.01 | |
| Return on tangible assets | -0.19 | -0.05 | -0.05 | -0.03 | -0.01 | |
| Graham Net | -220.96 | -217.92 | -185.39 | -235.58 | -217.91 | |
| Working capital | 77.61M | 55.63M | 12.53M | 4.1M | 12.19M | |
| Tangible asset value | -484.59M | -512.38M | -395.18M | -625.42M | -410.97M | |
| Net current asset value | -836.41M | -858.44M | -730.61M | -944.74M | -858.37M | |
| Invested capital | 18.15 | 51.32 | 5.5 | -8.09 | 4.73 | |
| Average receivables | 81.5M | 81.44M | 81.49M | 82.87M | 98.73M | |
| Average payables | 11.83M | 11.4M | 11.39M | 12M | 13.08M | |
| Average inventory | 16.38M | 17.56M | 14.57M | 13.38M | 6.23M | |
| Days sales outstanding | 44.88 | 44.32 | 42.19 | 43.09 | 55.54 | |
| Days payables outstanding | 8.09 | 6.42 | 7.74 | 6.88 | 8.55 | |
| Days of inventory on hand | 13.06 | 9.3 | 8.83 | 7.49 | 0 | |
| Receivables turnover | 2.01 | 2.03 | 2.13 | 2.09 | 1.62 | |
| Payables turnover | 11.13 | 14.01 | 11.63 | 13.08 | 10.52 | |
| Inventory turnover | 6.89 | 9.67 | 10.19 | 12.02 | 0 | |
| ROE | -2.33 | -1.61 | -0.16 | 0.16 | -0.05 | |
| Capex per share | -1.53 | -1.33 | -1.11 | -1.11 | -0.66 |
ATIP Frequently Asked Questions
What is ATI Physical Therapy, Inc. stock symbol ?
ATI Physical Therapy, Inc. is a US stock , located in Bolingbrook of Il and trading under the symbol ATIP
What is ATI Physical Therapy, Inc. stock quote today ?
ATI Physical Therapy, Inc. stock price is $4.03 today.
Is ATI Physical Therapy, Inc. stock public?
Yes, ATI Physical Therapy, Inc. is a publicly traded company.
Company Profile
- Volume Average 5.58K
- Market Capitalization 17.26M
- Employee 6K
- CEO Ms. Sharon Vitti
- Headquarters Bolingbrook,IL,US
- IPO Date 2020-10-02
-
Website
https://www.atipt.com 
ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity assessment, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in progressive therapies; and sports medicine, including onsite sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI Physical Therapy name. As of December 31, 2021, it had 910 owned and 20 managed clinics. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.
